Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the acf domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-includes/functions.php on line 6131

Notice: Undefined offset: 0 in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10

Notice: Trying to get property 'name' of non-object in /var/www/vhosts/viewstream-media.com/cri.viewstream-media.com/wp-content/themes/cri/single.php on line 10
Emerging Concepts in Prostate Cancer Immunotherapy
stdClass Object ( [getLoginUrlResponse] => stdClass Object ( [JSESSIONID] => C41AD6336289ADCDAB922A7B744D70E8.app30061b [routing_id] => 00000000.app30061b [url] => https://give.cancerresearch.org/site/CRConsAPI;jsessionid=00000000.app30061b?NONCE_TOKEN=CCCC06AFD687DDFD24EB1755FBEB5609 [token] => 1q9wONzht4XzE5IA6-QNaTeZevC2PVFZKNiUpEU2vGI238lgPOsyE2LaH_7zWlOrOUb9BiG481J5xJF4brNZqUWBMKEwH8tENBNZnaI ) ) test

Cancer Research Institute Event Calendar

Subscribe

Share

Emerging Concepts in Prostate Cancer Immunotherapy

On May 27, 2015, James Gulley, M.D., Ph.D., and Ravi Madan, M.D., discussed some of the basic concepts of therapies that are designed to stimulate the immune system and treat patients with prostate cancer. They focused on immunotherapies that are FDA approved or in the late stages of clinical development for prostate cancer and discussed potential future roles of cancer immunotherapy, including data that suggest that immune therapies can be combined with other types of therapies. They also addressed when to use and not to use immunotherapy and provide data about what to expect clinically from this type of treatment. 

This webinar is part of the Cancer Research Institute's webinar series, "Cancer Immunotherapy and You," which are offered free to the public and feature informative updates for patients and caregivers from leaders in cancer immunotherapy, followed by a Q&A. This webinar was made possible by the generous support of Bavarian Nordic. For more information on this webinar, or to register for upcoming webinars, please visit www.cancerresearch.org/webinars.

Read more:

This site is registered on wpml.org as a development site.